Home-based peroneal electrical transcutaneous NeuroModulation (peroneal eTNM®) in Parkinson’s disease as “add-on” treatment – Results of a pilot study
Larger and more rigorously designed studies are needed to validate the utility and position of peroneal eTNM® in the treatment of patients with PD.
Authors
- Martin B. Schmidt (ORCID: https://orcid.org/0000-0003-2458-6635)
- Martin Slovák (ORCID: https://orcid.org/0009-0004-2166-4401)
- Petra Bártová (ORCID: https://orcid.org/0000-0002-4191-9561)
- Lukáš Peter (ORCID: https://orcid.org/0000-0003-4351-8291)
- David Školoudík (ORCID: https://orcid.org/0000-0002-2651-3424)
- Jan Krhút (ORCID: https://orcid.org/0000-0003-4205-5926)
- Roman Dvořák (ORCID: https://orcid.org/0000-0003-3749-5724)
- Eva Augste (ORCID: https://orcid.org/0009-0000-5757-6746)
- Filip Strouhal
Institutions
- VSB - Technical University of Ostrava (CZ)
- University of Ostrava (CZ)
- University Hospital Ostrava (CZ)
Publication Details
- Journal
- Clinical Parkinsonism & Related Disorders
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.prdoa.2025.100321
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00